Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion

AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiogr...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Chong Zhang [verfasserIn] Tong-Tong Niu [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2016

Schlagwörter:	branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation

Übergeordnetes Werk:	In: Guoji Yanke Zazhi - Press of International Journal of Ophthalmology (IJO PRESS), 2017, 16(2016), 4, Seite 702-705
Übergeordnetes Werk:	volume:16 ; year:2016 ; number:4 ; pages:702-705

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.3980/j.issn.1672-5123.2016.4.28

Katalog-ID:	DOAJ033386382

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ033386382
003	DE-627
005	20230502092330.0
007	cr uuu---uuuuu
008	230226s2016 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.3980/j.issn.1672-5123.2016.4.28 \|2 doi
035			\|a (DE-627)DOAJ033386382
035			\|a (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RE1-994
100	0		\|a Chong Zhang \|e verfasserin \|4 aut
245	1	0	\|a Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.
650		4	\|a branch retinal vein occlusion
650		4	\|a macular edema
650		4	\|a ranibizumab
650		4	\|a grid pattern laser photocoagulation
653		0	\|a Ophthalmology
700	0		\|a Tong-Tong Niu \|e verfasserin \|4 aut
773	0	8	\|i In \|t Guoji Yanke Zazhi \|d Press of International Journal of Ophthalmology (IJO PRESS), 2017 \|g 16(2016), 4, Seite 702-705 \|w (DE-627)1680946854 \|x 16725123 \|7 nnns
773	1	8	\|g volume:16 \|g year:2016 \|g number:4 \|g pages:702-705
856	4	0	\|u https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 \|z kostenfrei
856	4	0	\|u http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1672-5123 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1672-5123 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_11
912			\|a GBV_ILN_2817
951			\|a AR
952			\|d 16 \|j 2016 \|e 4 \|h 702-705

Indexfelder

author_variant	c z cz t t n ttn
matchkey_str	article:16725123:2016----::fetfaiiuawtmclrrdatrpooogltofrauaeeaasd
hierarchy_sort_str	2016
callnumber-subject-code	RE
publishDate	2016
allfields	10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705
spelling	10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705
allfields_unstemmed	10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705
allfieldsGer	10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705
allfieldsSound	10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705
language	English
source	In Guoji Yanke Zazhi 16(2016), 4, Seite 702-705 volume:16 year:2016 number:4 pages:702-705
sourceStr	In Guoji Yanke Zazhi 16(2016), 4, Seite 702-705 volume:16 year:2016 number:4 pages:702-705
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology
isfreeaccess_bool	true
container_title	Guoji Yanke Zazhi
authorswithroles_txt_mv	Chong Zhang @@aut@@ Tong-Tong Niu @@aut@@
publishDateDaySort_date	2016-01-01T00:00:00Z
hierarchy_top_id	1680946854
id	DOAJ033386382
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033386382</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502092330.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033386382</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Chong Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">branch retinal vein occlusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">macular edema</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ranibizumab</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">grid pattern laser photocoagulation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tong-Tong Niu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">16(2016), 4, Seite 702-705</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:702-705</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">702-705</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Chong Zhang
spellingShingle	Chong Zhang misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
authorStr	Chong Zhang
ppnlink_with_tag_str_mv	@@773@@(DE-627)1680946854
format	electronic Article
delete_txt_mv	keep
author_role	aut aut
collection	DOAJ
remote_str	true
callnumber-label	RE1-994
illustrated	Not Illustrated
issn	16725123
topic_title	RE1-994 Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation
topic	misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology
topic_unstemmed	misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology
topic_browse	misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Guoji Yanke Zazhi
hierarchy_parent_id	1680946854
hierarchy_top_title	Guoji Yanke Zazhi
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1680946854
title	Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
ctrlnum	(DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21
title_full	Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
author_sort	Chong Zhang
journal	Guoji Yanke Zazhi
journalStr	Guoji Yanke Zazhi
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2016
contenttype_str_mv	txt
container_start_page	702
author_browse	Chong Zhang Tong-Tong Niu
container_volume	16
class	RE1-994
format_se	Elektronische Aufsätze
author-letter	Chong Zhang
doi_str_mv	10.3980/j.issn.1672-5123.2016.4.28
author2-role	verfasserin
title_sort	effect of ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
callnumber	RE1-994
title_auth	Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
abstract	AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.
abstractGer	AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.
abstract_unstemmed	AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817
container_issue	4
title_short	Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
url	https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf https://doaj.org/toc/1672-5123
remote_bool	true
author2	Tong-Tong Niu
author2Str	Tong-Tong Niu
ppnlink	1680946854
callnumber-subject	RE - Ophthalmology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.3980/j.issn.1672-5123.2016.4.28
callnumber-a	RE1-994
up_date	2024-07-03T17:28:22.158Z
_version_	1803579767822221312
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033386382</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502092330.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2016 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033386382</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Chong Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">branch retinal vein occlusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">macular edema</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ranibizumab</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">grid pattern laser photocoagulation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tong-Tong Niu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">16(2016), 4, Seite 702-705</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:702-705</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">702-705</subfield></datafield></record></collection>
score	7.397518

Nicht das Richtige dabei?

Schreiben Sie uns!

Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?